title: Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data.
abstract: Increasing mortality and morbidity associated with opioid analgesics has led to concerns about their misuse and abuse, even when obtained through a prescription. These concerns have been most pronounced in the United States, but limited data make it difficult to determine whether it is a problem in other countries. We investigated opioid analgesic misuse and abuse in participants from the Global Drug Survey 2015 resident in the United States (N = 1334), United Kingdom (N = 1199), France (N = 1258), Germany (N = 866), and Australia (N = 1013) who had used at least 1 prescription opioid analgesic medication in the past year. We also investigated the relationship with polysubstance use, one of the most consistent predictors of problematic opioid analgesic use. Data included misuse and abuse of codeine, hydrocodone, oxycodone, and tramadol; ability to obtain a prescription; different sources for obtaining drugs; and past-year use of benzodiazepines and illicit drugs. In multilevel models, country of residence accounted for less than 3% of the variance in opioid analgesic misuse or abuse. Adjusting for country of residence and sociodemographic factors, use of illicit drugs and benzodiazepines was associated with 4-fold greater odds of misuse (odds ratio 4.36, 95% confidence interval 3.29-5.93) and 6-fold greater odds of abuse compared with not using either drug (odds ratio 6.49, 95% confidence interval 4.0-10.48), although the strength of the association with abuse varied by country. Misuse and abuse by those prescribed opioid analgesics seem to be a problem that is not limited to the United States and warrant attention on an international scale.
authors.affiliation: aNational Addictions Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom bCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia cInstitute for Social Science Research, The University of Queensland, Brisbane, Australia dSouth London and Maudsley NHS Trust, London, United Kingdom eGlobal Drug Survey, London, United Kingdom.
authors.forename: Katherine I
authors.initials: KI
authors.lastname: Morley
authors.forename: Jason A
authors.initials: JA
authors.lastname: Ferris
authors.forename: Adam R
authors.initials: AR
authors.lastname: Winstock
authors.forename: Michael T
authors.initials: MT
authors.lastname: Lynskey
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid; D000076064:Drug Misuse / Q000706:statistics & numerical data*; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D014943:Global Health / Q000706:statistics & numerical data*; D006801:Humans; D038622:Internationality; D008297:Male; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000453:epidemiology*; D019338:Polypharmacy; D015995:Prevalence; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000453:epidemiology*
chemical_list: D000701:Analgesics, Opioid